BIOMAT Database Logo BIOMAT Database Logo

Influence of food intake on the bioavailability of thioctic acid enantiomers. 1996

C H Gleiter, and B S Schug, and R Hermann, and M Elze, and H H Blume, and U Gundert-Remy

UI MeSH Term Description Entries
D008063 Thioctic Acid An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS. Lipoic Acid,Alpha-Lipogamma,Alpha-Lipon Stada,Alpha-Liponsaure Sofotec,Alpha-Lippon AL,Alphaflam,Azulipont,Fenint,Juthiac,Liponsaure-ratiopharm,MTW-Alphaliponsaure,Neurium,Pleomix-Alpha,Pleomix-Alpha N,Thioctacid,Thioctacide T,Thiogamma Injekt,Thiogamma oral,Tromlipon,Verla-Lipon,alpha-Lipoic Acid,alpha-Liponaure Heumann,alpha-Liponsaure von ct,alpha-Vibolex,biomo-lipon,duralipon,espa-lipon,Acid, alpha-Lipoic,Alpha Lipogamma,Alpha Lipon Stada,Alpha Liponsaure Sofotec,Alpha Lippon AL,AlphaLipogamma,AlphaLipon Stada,AlphaLiponsaure Sofotec,AlphaLippon AL,Injekt, Thiogamma,Liponsaure ratiopharm,Liponsaureratiopharm,MTW Alphaliponsaure,MTWAlphaliponsaure,Pleomix Alpha,Pleomix Alpha N,PleomixAlpha,PleomixAlpha N,Verla Lipon,VerlaLipon,alpha Lipoic Acid,alpha Liponaure Heumann,alpha Liponsaure von ct,alpha Vibolex,alphaLiponaure Heumann,alphaLiponsaure von ct,alphaVibolex,biomo lipon,biomolipon,espa lipon,espalipon
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D018565 Food-Drug Interactions The pharmacological result, either desirable or undesirable, of drugs interacting with components of the diet. (From Stedman, 25th ed) Drug-Food Interactions,Food Interactions,Drug Food Interactions,Drug-Food Interaction,Food Drug Interactions,Food Interaction,Food-Drug Interaction,Interaction, Drug-Food,Interaction, Food,Interaction, Food-Drug,Interactions, Drug-Food,Interactions, Food,Interactions, Food-Drug
D018592 Cross-Over Studies Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed) Cross-Over Design,Cross-Over Trials,Crossover Design,Crossover Studies,Crossover Trials,Cross Over Design,Cross Over Studies,Cross Over Trials,Cross-Over Designs,Cross-Over Study,Crossover Designs,Crossover Study,Design, Cross-Over,Design, Crossover,Designs, Cross-Over,Designs, Crossover,Studies, Cross-Over,Studies, Crossover,Study, Cross-Over,Study, Crossover,Trial, Cross-Over,Trial, Crossover,Trials, Cross-Over,Trials, Crossover
D019518 Postprandial Period The time frame after a meal or FOOD INTAKE. Postcibal Period,Period, Postcibal,Period, Postprandial,Periods, Postcibal,Periods, Postprandial,Postcibal Periods,Postprandial Periods

Related Publications

C H Gleiter, and B S Schug, and R Hermann, and M Elze, and H H Blume, and U Gundert-Remy
Influence of food intake on the bioavailability of zuclopenthixol.
January 1987, Drug-nutrient interactions,
C H Gleiter, and B S Schug, and R Hermann, and M Elze, and H H Blume, and U Gundert-Remy
Bioavailability of mefenamic acid: influence of food and water intake.
September 1986, Journal of pharmaceutical sciences,
C H Gleiter, and B S Schug, and R Hermann, and M Elze, and H H Blume, and U Gundert-Remy
On the influence of concomitant food intake on sulfonamide bioavailability.
January 1976, Acta medica Scandinavica,
C H Gleiter, and B S Schug, and R Hermann, and M Elze, and H H Blume, and U Gundert-Remy
Gastric emptying in patients with insulin dependent diabetes mellitus and bioavailability of thioctic acid-enantiomers.
January 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
C H Gleiter, and B S Schug, and R Hermann, and M Elze, and H H Blume, and U Gundert-Remy
Influence of food intake on the bioavailability of urapidil in healthy volunteers.
June 1989, International journal of clinical pharmacology, therapy, and toxicology,
C H Gleiter, and B S Schug, and R Hermann, and M Elze, and H H Blume, and U Gundert-Remy
Influence of food intake on the bioavailability and efficacy of oral calcitonin.
April 2009, British journal of clinical pharmacology,
C H Gleiter, and B S Schug, and R Hermann, and M Elze, and H H Blume, and U Gundert-Remy
Influence of food intake on bioavailability of theophylline in premature infants.
January 1982, European journal of clinical pharmacology,
C H Gleiter, and B S Schug, and R Hermann, and M Elze, and H H Blume, and U Gundert-Remy
Oral mercaptopurine in childhood leukemia: influence of food intake on bioavailability.
January 1989, Pediatric hematology and oncology,
C H Gleiter, and B S Schug, and R Hermann, and M Elze, and H H Blume, and U Gundert-Remy
Bioavailability of oxazepam: absence of influence of food intake.
May 1977, Acta pharmacologica et toxicologica,
C H Gleiter, and B S Schug, and R Hermann, and M Elze, and H H Blume, and U Gundert-Remy
[Influence of food intake on the bioavailability of an oral form of tiapride].
January 1982, Therapie,
Copied contents to your clipboard!